SCHEMBL6081609

SCHEMBL6081609

CCOC(=O)CC(=O)CCC1OCCCO1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.44
MGAM O43451 1/20 0.44
SI P14410 1/20 0.44
MGAM2 Q2M2H8 1/20 0.44
LMNA P02545 3/20 0.36
POLB P06746 2/20 0.36
TSHR P16473 2/20 0.36
ALDH1A1 P00352 5/20 0.36
USP2 O75604 1/20 0.35
ALOX15 P16050 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
RAB9A P51151 2/20 0.34
CYP1A2 P05177 2/20 0.34
HPGD P15428 2/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
NPC1 O15118 1/20 0.34
TP53 P04637 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
TRPA1 O75762 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6081635 0.93 GAA (0.47) GAAMGAMSIMGAM2LMNA
SCHEMBL6081933 0.91 GAA (0.41) GAAMGAMSIMGAM2LMNA
SCHEMBL13556317 0.86 ALDH1A1 (0.45) GAAMGAMSIMGAM2LMNA
SCHEMBL6081360 0.83 LMNA (0.48) GAAMGAMSIMGAM2LMNA
SCHEMBL4994207 0.82 LMNA (0.43) GAAMGAMSIMGAM2LMNA
SCHEMBL3588952 0.80 TSHR (0.45) GAAMGAMSIMGAM2LMNA
SCHEMBL5001247 0.80 GAA (0.47) GAAMGAMSIMGAM2POLB
SCHEMBL18900660 0.77 TDP1 (0.36) LMNAPOLBUSP2TDP1
SCHEMBL5313576 0.77 MGAM (0.47) GAAMGAMSIMGAM2ALDH1A1
SCHEMBL12321268 0.77 FAAH (0.38) LMNAPOLBTSHRALDH1A1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060089398-A1 Isoxazole carboxamide derivatives as ghrelin receptor modulators NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2006-04-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060089398-A1 Isoxazole carboxamide derivatives as ghrelin receptor modulators GPR119, GIPR, GLP1R GAA 359/4885MGAM 634/4885SI 90/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.